Goldman Sachs’s Arotech Corporation ARTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-18,385
Closed -$65K 6583
2017
Q4
$65K Buy
+18,385
New +$71K ﹤0.01% 5880
2017
Q2
Sell
-48,311
Closed -$143K 7087
2017
Q1
$143K Buy
48,311
+20,461
+73% +$79K ﹤0.01% 5899
2016
Q4
$97K Buy
+27,850
New +$92.6K ﹤0.01% 6161
2016
Q1
Sell
-10,140
Closed -$21K 7442
2015
Q4
$21K Buy
+10,140
New +$16.6K ﹤0.01% 6841
2015
Q3
Sell
-21,195
Closed -$51K 7591
2015
Q2
$51K Buy
+21,195
New +$57.9K ﹤0.01% 6859

Other funds holding ARTX

Goldman Sachs's ARTX Position: Q1 2018 in Review

Goldman Sachs sold out of Arotech Corporation (ARTX) in Q1 2018, closing a stake of 18,385 shares — an estimated $65K sold.

Goldman Sachs first reported a position in ARTX in Q2 2015 and held it in 5 quarters. The position peaked at $143K in Q1 2017. 51 funds tracked by Wall St. Rank hold ARTX as of Q1 2018.

  • Goldman Sachs reported no remaining Arotech Corporation position as of Q1 2018 after selling out during the quarter.
  • Goldman Sachs sold 18,385 Arotech Corporation shares in Q1 2018, an estimated $65K.
  • Goldman Sachs first reported a position in Arotech Corporation in Q2 2015 and held it in 5 quarters.
  • Goldman Sachs's Arotech Corporation position peaked at $143K in Q1 2017.
  • 51 funds tracked by Wall St. Rank held Arotech Corporation as of Q1 2018.

Based on Goldman Sachs's 13F filing for Q1 2018, filed 15 May 2018.